IGC PHARMA, INC. Gain (Loss) on Disposition of Assets
IGC PHARMA, INC. (IGC) reported Gain (Loss) on Disposition of Assets of -$39.00 thousand for the 9-month period ending 2022-12-31, per its 10-Q filed 2023-02-14.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2023-02-14
- IGC PHARMA, INC. gain (loss) on disposition of assets for the quarter ending 2022-12-31 was $6.00K.
- IGC PHARMA, INC. gain (loss) on disposition of assets for the quarter ending 2022-09-30 was $23.00K.
- IGC PHARMA, INC. gain (loss) on disposition of assets for the quarter ending 2022-06-30 was -$68.00K.
- IGC PHARMA, INC. gain (loss) on disposition of assets for the quarter ending 2021-12-31 was $0.00.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month |
|---|---|---|---|
| 2022-12-31 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-14 | $29.00K derived: sum of 2 quarters · filed 2023-02-14 | -$39.00K 10-Q · filed 2023-02-14 |
| 2022-09-30 | $23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-01 | -$45.00K 10-Q · filed 2022-11-01 | |
| 2022-06-30 | -$68.00K 10-Q · filed 2022-08-05 | ||
| 2021-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-14 | $0.00 derived: sum of 2 quarters · filed 2023-02-14 | $0.00 10-Q · filed 2023-02-14 |
| 2021-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-01 | $0.00 10-Q · filed 2022-11-01 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |